跳至主要内容
临床试验/IRCT20130311012781N5
IRCT20130311012781N5尚未招募2 期

Evaluation the efficacy of colchicine on secondary prevention of ischemic stroke in patients with atrial fibrillation (AF)

Ahvaz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients who are admitted with a diagnosis of ischemic stroke and have AF at the time of hospitalization
  • The considered age group is 18 years or older

排除标准

  • Allergies and sensitivities to colchicine
  • Patients who are taking corticosteroids, methotrexate, TNFa-blockers, interleukin1 -1b antagonist
  • Patients with inflammatory disease such as lupus, rheumatoid arthritis, connective tissue disease or chronic infections
  • Patients with sever Renal failure ( GFR <30 ml/min/1.73 m2) or liver failure (ALT/AST > 2 above normal
  • Patients with moderate to severe cytopenia (plt < 100000, neutrophil count < 1500) or blood dyscrasia
  • Patients who are contraindicated for rivaroxaban
  • Pregnant or lactating women or women in childbearing age who do not take appropriate contraception

研究者

相似试验